首页> 外国专利> Production mannered null human origin blood coagulation factor or blood clotting control factor of blood coagulation factor

Production mannered null human origin blood coagulation factor or blood clotting control factor of blood coagulation factor

机译:生产方式无效的人源凝血因子或凝血因子的凝血控制因子

摘要

PROBLEM TO BE SOLVED: To prepare a blood coagulation factor-or blood coagulation control factor-defective model animal useful for developing medicines for treating hemophilia inhibitors by administering a human blood coagulation factor, or the like, into an anthropoid animal to cause an immune reaction, then treating the animal under specific conditions. ;SOLUTION: This blood coagulation factor or blood coagulation control factor-defective model animal is obtained by administering a human blood coagulation factor or blood coagulation control factor both dependent on vitamin K into an anthropoid animal phylogenetically comprising anthropoidea animals or larger, such as a large monkey, to cause an immune reaction, thus neutralizing a blood coagulation factor or blood coagulation control factor having the same function as the human factor in the body of the anthropoid animal to neutralize the blood coagulation factor or blood coagulation control factor of the animal by the immune reaction. The human blood coagulation factor or blood coagulation control factor is preferably subcutaneously or intravenously administered.;COPYRIGHT: (C)2000,JPO
机译:解决的问题:通过向类人动物施用人凝血因子等以引起免疫反应,制备用于开发用于治疗血友病抑制剂的药物的凝血因子或凝血控制因子缺陷的模型动物。 ,然后在特定条件下处理动物。 ;解决方案:该血液凝结因子或血液凝结控制因子缺陷的模型动物是通过将既依赖于维生素K的人类血液凝结因子或血液凝结控制因子施用到系统发育上的类人猿动物(例如大型人猿)中而获得的。猴子,从而引起免疫反应,从而在类人动物体内中和具有与人为因子相同功能的凝血因子或凝血控制因子,从而通过动物中和动物的凝血因子或凝血控制因子。免疫反应。人凝血因子或凝血控制因子优选经皮下或静脉内施用。版权所有:(C)2000,JPO

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号